Context Therapeutics Inc
F:6K9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Context Therapeutics Inc
F:6K9
|
US |
|
B
|
Blue Label Telecoms Ltd
XBER:5TP
|
ZA |
|
H
|
Healthcare Trust Of America Inc
F:HT01
|
US |
|
N
|
National Bank of Canada
OTC:NTIOF
|
CA |
|
A
|
Agnico Eagle Mines Ltd
XMUN:AE9
|
CA |
|
Secom Co Ltd
F:XSC
|
JP |
|
S
|
Surgery Partners Inc
F:1SP
|
US |
|
L
|
L3harris Technologies Inc
DUS:HRS
|
US |
|
Z
|
Zijin Mining Group Co Ltd
DUS:FJZ
|
CN |
|
Bilfinger SE
OTC:BFLBF
|
DE |
|
C
|
Campbell Soup Co
SWB:CSC
|
US |
|
C
|
Chow Tai Fook Jewellery Group Ltd
XBER:1CT
|
HK |
|
B
|
Barrick Gold Corp
DUS:ABR
|
CA |
|
AxoGen Inc
F:LT3
|
US |
|
S
|
SandRidge Energy Inc
SWB:SA2D
|
US |
|
L
|
Lindsay Corp
F:LMF
|
US |
|
H
|
Helmerich and Payne Inc
XMUN:HPC
|
US |
|
Rivian Automotive Inc
MIL:1RIVN
|
US |
|
U
|
UniCredit SpA
WSE:UCG
|
IT |
|
B
|
Bilfinger SE
DUS:GBF
|
DE |
Wall St Price Targets
6K9 Price Targets Summary
Context Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
6K9 is 2.89 EUR with a low forecast of 1.91 EUR and a high forecast of 4.46 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 6K9's stock price target?
Price Target
2.89
EUR
According to Wall Street analysts, the average 1-year price target for
6K9 is 2.89 EUR with a low forecast of 1.91 EUR and a high forecast of 4.46 EUR.